Measuring the impact of COVID-19 vaccination and immunity waning: A modelling study for Portugal
- PMID: 36404429
- PMCID: PMC9576223
- DOI: 10.1016/j.vaccine.2022.10.007
Measuring the impact of COVID-19 vaccination and immunity waning: A modelling study for Portugal
Abstract
Vaccination strategies to control COVID-19 have been ongoing worldwide since the end of 2020. Understanding their possible effect is key to prevent future disease spread. Using a modelling approach, this study intends to measure the impact of the COVID-19 Portuguese vaccination strategy on the effective reproduction number and explore three scenarios for vaccine effectiveness waning. Namely, the no-immunity-loss, 1-year and 3-years of immunity duration scenarios. We adapted an age-structured SEIR deterministic model and used Portuguese hospitalisation data for the model calibration. Results show that, although the Portuguese vaccination plan had a substantial impact in reducing overall transmission, it might not be sufficient to control disease spread. A significant vaccination coverage of those above 5 years old, a vaccine effectiveness against disease of at least 80% and softer non-pharmaceutical interventions (NPIs), such as mask usage and social distancing, would be necessary to control disease spread in the worst scenario considered. The immunity duration scenario of 1-year displays a resurgence of COVID-19 hospitalisations by the end of 2021, the same is observed in 3-year scenario although with a lower magnitude. The no-immunity-loss scenario presents a low increase in hospitalisations. In both the 1-year and 3-year scenarios, a vaccination boost of those above 65 years old would result in a 53% and 38% peak reduction of non-ICU hospitalisations, respectively. These results suggest that NPIs should not be fully phased-out but instead be combined with a fast booster vaccination strategy to reduce healthcare burden.
Keywords: COVID-19; Compartmental models; Epidemiology; SEIR model; Vaccination; Vaccine effectiveness waning.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures



Similar articles
-
Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.BMC Med. 2022 Feb 18;20(1):80. doi: 10.1186/s12916-022-02241-3. BMC Med. 2022. PMID: 35177062 Free PMC article.
-
Mathematical modelling of vaccination rollout and NPIs lifting on COVID-19 transmission with VOC: a case study in Toronto, Canada.BMC Public Health. 2022 Jul 15;22(1):1349. doi: 10.1186/s12889-022-13597-9. BMC Public Health. 2022. PMID: 35841012 Free PMC article.
-
Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.JAMA Netw Open. 2021 Jun 1;4(6):e2110782. doi: 10.1001/jamanetworkopen.2021.10782. JAMA Netw Open. 2021. PMID: 34061203 Free PMC article.
-
Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?Expert Rev Vaccines. 2022 Nov;21(11):1541-1553. doi: 10.1080/14760584.2022.2117693. Epub 2022 Sep 5. Expert Rev Vaccines. 2022. PMID: 36039786 Review.
-
Comparison of COVID-19 and seasonal influenza under different intensities of non-pharmaceutical interventions and vaccine effectiveness.Front Public Health. 2022 Sep 27;10:973088. doi: 10.3389/fpubh.2022.973088. eCollection 2022. Front Public Health. 2022. PMID: 36238257 Free PMC article. Review.
Cited by
-
What we talk about when we talk about COVID-19 vaccination campaign impact: a narrative review.Front Public Health. 2023 May 11;11:1126461. doi: 10.3389/fpubh.2023.1126461. eCollection 2023. Front Public Health. 2023. PMID: 37250083 Free PMC article. Review.
-
Pharmaceutical and non-pharmaceutical interventions for controlling the COVID-19 pandemic.R Soc Open Sci. 2023 Dec 20;10(12):230621. doi: 10.1098/rsos.230621. eCollection 2023 Dec. R Soc Open Sci. 2023. PMID: 38126062 Free PMC article.
-
A Scoping Review of Three Dimensions for Long-Term COVID-19 Vaccination Models: Hybrid Immunity, Individual Drivers of Vaccinal Choice, and Human Errors.Vaccines (Basel). 2022 Oct 14;10(10):1716. doi: 10.3390/vaccines10101716. Vaccines (Basel). 2022. PMID: 36298581 Free PMC article.
-
Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review.Syst Rev. 2024 Jan 16;13(1):30. doi: 10.1186/s13643-023-02411-1. Syst Rev. 2024. PMID: 38229123 Free PMC article.
-
Understanding spatiotemporal patterns of COVID-19 incidence in Portugal: A functional data analysis from August 2020 to March 2022.PLoS One. 2024 Feb 1;19(2):e0297772. doi: 10.1371/journal.pone.0297772. eCollection 2024. PLoS One. 2024. PMID: 38300912 Free PMC article.
References
-
- COVID-19: Relatório de situação (2021).
-
- Departamento de Doenças Infeciosas. Instituto Nacional de Saúde Doutor Ricardo Jorge; 2021. Diversidade genética do novo coronavírus SARS-CoV-2 (COVID-19)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical